Using a Variety of Modalities to Measure Both Small and Large Fiber Neuropathy Provides More Accurate Estimates of the Prevalence of Diabetic Neuropathies
In April 2024, the Journal of Diabetes and Its Complications published “Contemporary prevalence of diabetic neuropathies in individuals with Type 1 and Type 2 diabetes in a Danish tertiary outpatient clinic”, a large scale study from researchers at the Steno Diabetes Center in Copenhagen, Denmark. Researchers assessed 822 individuals with Type 1 and 899 individuals with Type 2 diabetes for both distal symmetric polyneuropathy (DPN) and diabetic autonomic neuropathy (DAN) using a variety of modalities in order to make population-based prevalence estimates.
Pioneering Real Change in Diabetes Care
Up to 70% of people with diabetes will be affected by diabetic peripheral neuropathy, and nearly half have no symptoms to alert them that it’s happening. This often silent condition increases the risk of foot ulcers and potential amputations. Patients with diabetic foot ulcers have a two-fold greater increase in mortality.